Extract Labs, Inc. Mai Tai 20mg Gummies Brand Recall (Saf...
Extract Labs, Inc.'s Mai Tai 20mg Gummies Brand Name: None - has been recalled due to a safety concern. Do not consume this product. Throw it away or return it to the place of purchase for a refund.
By RecallRadar Editorial Team
Sourced from FDA. Last verified March 4, 2026.
On this page
Free checker
Check if you qualify
See whether your device may qualify for a free repair or replacement program before you spend money.
Check if you qualifyKey facts
- Date announced
- August 26, 2025
- Source agency
- FDA
This recall involves safety concerns. Take action promptly.
✨ Plain-English Summary
Extract Labs, Inc.'s Mai Tai 20mg Gummies Brand Name: None - has been recalled due to a safety concern. Do not consume this product. Throw it away or return it to the place of purchase for a refund.
Is This Recall Still Active?
Status: No - Expired
This recall is no longer active. You can still review details here for historical reference and confirmation.
What's Being Recalled
Quoted source excerpt from the official notice.
Potential peanut protein cross-contact.
Quick Info
Key facts from the official notice, kept in the article flow for easy cross-checking.
- Brand
- Extract labs, inc.
- Category
- food
- Source agency
- FDA
- Announced
- August 26, 2025
- Country
- US
- Status
- Expired
Who's Affected
Specific models and identifiers listed in the source notice:
Model #1
Lot: 25JD042507A EXP: 07/2027 Printed on bulk bag identifier adhesive
| # | Model |
|---|---|
| 1 | Lot: 25JD042507A EXP: 07/2027 Printed on bulk bag identifier adhesive |
Technical model codes are manufacturer identifiers. Match both the product name and model code from your device settings, label, or packaging.
What You Should Do
Follow the remedy path from the official notice using the exact model and serial details above.
- 1## Mai Tai 20mg Gummies Brand Name: None - unlabeled bulk (private-label consignee) Generic Name: Dietary Supplement Strength: 20mg CBD and 20mg D9 THC per gummy Dosage: Not declared at bulk stage (consignee determines serving size) Form: Gummy Administrat Agency: FDA | Category: food | Date: 2025-08-26 Reason: Potential peanut protein cross-contact. What to do:
- 2Stop using the product if it matches your lot/model.
- 3Compare your product details with the FDA recall notice.
- 4Follow the manufacturer's remedy instructions (refund, replacement, or disposal).
This program has ended. The official source page may no longer be available.
Source & Verification
This page summarizes the official notice and keeps key facts easy to verify.
- Official source
- FDA
- Announced by source
- August 26, 2025
- Last reviewed by RecallRadar
- March 4, 2026
Frequently Asked Questions
Am I affected by this recall?
Check the affected models section on this page. The official notice currently lists Lot: 25JD042507A EXP: 07/2027 Printed on bulk bag identifier adhesive.
What is the remedy for this recall?
## Mai Tai 20mg Gummies Brand Name: None - unlabeled bulk (private-label consignee) Generic Name: Dietary Supplement Strength: 20mg CBD and 20mg D9 THC per gummy Dosage: Not declared at bulk stage (consignee determines serving size) Form: Gummy Administrat Agency: FDA | Category: food | Date: 2025-08-26 Reason: Potential peanut protein cross-contact. What to do: 1. Stop using the product if it matches your lot/model. 2. Compare your product details with the FDA recall notice. 3. Follow the manufacturer's remedy instructions (refund, replacement, or disposal).
Where can I verify recall details?
Use the official source link in this page to confirm dates, eligibility, and next steps: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts
Keep browsing with these internal hubs: extract labs, inc. recall hub and Food & Drug recall hub.
Official Resources
Use these primary sources for final eligibility and claim instructions.
View official notice from FDASee an inaccuracy?
Help us improve the accuracy of this recall information.
On this page
Free checker
Check if you qualify
See whether your device may qualify for a free repair or replacement program before you spend money.
Check if you qualifyKey facts
- Date announced
- August 26, 2025
- Source agency
- FDA
Related Recalls
amazon, Acetaminophen, Extra Strength, 500mg Caplets, 1000-count bottle, Distributed by: Amazon.com Services LLC, 410 Terry Avenue N., Seattle, WA 98109, Made in India, NDC 72288-692-01. UPC 1 95515 04888 0
Discoloration: consumer complaints received for discolored tablets
Oct 7, 2026
Paroxetine Extended-Release Tablets, 37.5mg, 30-count bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario, Canada M9L 1T9, Manufactured for: Apotex Corp., Weston, Florida 33326, NDC 60505-1318-3
Failed dissolution specifications.
Oct 7, 2026
FOCUS PI Hypromellose 0.7% Formula, 0.3 FL O (10 mL) per vial, STERILE, Manufactured for: Covalent Management, Inc., Manassas, VA 20109. NDC: 82724-007-19
Lack of Assurance of Sterility
Oct 7, 2026
Zoladex (goserelin) implant, 3.6 mg, One single-Use Syringe packaged in a carton, Rx only, Manufactured for: TerSera therapeutics LLC, Deerfield, IL 60015, BY: AstraZeneca UK Limited, Macclesfield, England, Product of Switzerland, website at www.zoladex.com, NDC 70720-950-36.
Temperature Abuse: Product sat in a non-temperature-controlled FedEx trailer at ambient outdoor conditions for 25.5 hours.
Oct 7, 2026
Buprenorphine Hydrochloride, Injection 0.3 mg/mL, Rx Only, 5 x 1 mL Single Dose Vials, Manufactured for: Endo USA, Malvern, PA, NDC 42023-179-05
Crystallization
Oct 7, 2026